Articles with "asct" as a keyword



Photo from wikipedia

High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Hematology"

DOI: 10.1007/s12185-019-02772-1

Abstract: To investigate the use of high-dose therapy and autologous stem cell transplantation (ASCT) for relapsed or high-risk diffuse large B-cell lymphoma (DLBCL) between 1990 and 2007, we conducted a nationwide survey using the registry database… read more here.

Keywords: asct; cell; cell transplantation; high risk ... See more keywords
Photo from wikipedia

Evaluating the impact of adaptive signal control technology on driver stress and behavior using real-world experimental data

Sign Up to like & get
recommendations!
Published in 2018 at "Transportation Research Part F: Traffic Psychology and Behaviour"

DOI: 10.1016/j.trf.2018.06.006

Abstract: Abstract While the operational and crash reduction benefits of adaptive signal control technology (ASCT) have long been investigated, the impact of this technology on driver behavior and stress is still uncertain. This study evaluated the… read more here.

Keywords: adaptive signal; signal control; asct; driver stress ... See more keywords
Photo by ibrahimboran from unsplash

Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progressionā€free and overall survival in elderly myeloma patients compared to standard of care

Sign Up to like & get
recommendations!
Published in 2022 at "European Journal of Haematology"

DOI: 10.1111/ejh.13861

Abstract: Despite the effectiveness of newer drugs for the treatment of multiple myeloma (MM), the outcomes are further improved by subsequent autologous stem cell transplantation (ASCT). Data on effectiveness in older patients are limited. We compared… read more here.

Keywords: asct; conditioning melphalan; melphalan 200; myeloma ... See more keywords
Photo from wikipedia

AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes

Sign Up to like & get
recommendations!
Published in 2019 at "Blood"

DOI: 10.1182/blood-2019-130307

Abstract: Introduction: Autologous stem cell transplantation (ASCT) remains an effective treatment option for many patients with systemic AL amyloidosis (AL). However, the decision to utilize maintenance therapy following ASCT remains controversial and largely unexplored. Studies have… read more here.

Keywords: pfs; maintenance therapy; maintenance; asct ... See more keywords
Photo by jareddrice from unsplash

Prognostic Impact of Tandem Autologous Stem Cell Transplantation (ASCT) in Different Response Subgroups after 1st ASCT

Sign Up to like & get
recommendations!
Published in 2017 at "Blood"

DOI: 10.1182/blood.v130.suppl_1.3295.3295

Abstract: Background High dose (HD) chemotherapy with melphalan and autologous stem cell transplantation (ASCT) have been considered a standard treatment for newly diagnosed multiple myeloma (MM) patients for more than 30 years. Two-course (tandem) ASCT proved… read more here.

Keywords: board directors; response; membership entity9s; entity9s board ... See more keywords
Photo by smartdicson from unsplash

Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.15_suppl.8002

Abstract: 8002 Background: High and comparable rates of MRD negativity were seen in NDMM pts after 4 28-day induction cycles with KRd followed by ASCT and 4 KRd consolidation (KRd_ASCT_KRd) and after 12 KRd cycles (KRd12),… read more here.

Keywords: krd asct; krd krd12; krd; risk ... See more keywords
Photo from wikipedia

Impact of time to relapse and response to salvage therapy on post autologous stem cell transplant outcomes in relapsed or refractory diffuse large B-cell lymphoma.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2021.39.15_suppl.e19501

Abstract: e19501 Background: The current standard of care for patients with relapsed or refractory (RR) diffuse large B-cell lymphoma (DLBCL) following frontline immunochemotherapy (IC) is salvage therapy, followed by high-dose chemotherapy and autologous stem cell transplant… read more here.

Keywords: therapy; time; salvage; salvage therapy ... See more keywords
Photo from wikipedia

Vincristine, Doxorubicin, and Dexamethasone Induction before Autologous Stem Cell Transplantation in Patients with AL Amyloidosis: A Retrospective Comparison with Frontline Stem Cell Transplantation

Sign Up to like & get
recommendations!
Published in 2022 at "Internal Medicine"

DOI: 10.2169/internalmedicine.9039-21

Abstract: Objective High-dose melphalan and autologous stem cell transplantation (ASCT) therapy for AL amyloidosis are now associated with reduced mortality based on the application of strict criteria. However, there is no long-term evidence concerning the performance… read more here.

Keywords: stem cell; asct; induction; cell transplantation ... See more keywords
Photo by martindorsch from unsplash

Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14235846

Abstract: Simple Summary Autologous stem cell transplantation (ASCT) represents a standard strategy for patients with relapsed and refractory (RR) Hodgkin Lymphoma (HL). Unfortunately, patients displaying some pre-transplant adverse predictors eventually progress, requiring further treatments and several… read more here.

Keywords: asct; anti pd1; high risk; consolidation ... See more keywords
Photo from wikipedia

The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma.

Sign Up to like & get
recommendations!
Published in 2020 at "Neoplasma"

DOI: 10.4149/neo_2020_200303n224

Abstract: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) remains a valuable therapeutic approach for relapsed and refractory (R/R) patients with diffuse large B-cell lymphoma (DLBCL). The aim of the study was to evaluate… read more here.

Keywords: patients diffuse; stem cell; transplantation; cell ... See more keywords